Biomedical composites of hydroxyapatite (HA) and bioactive glass (BG) have been difficult to obtain as a dense body without the undesirable occurrence of thermal reactions and phase degradation. Herein, HA-BG dense composites were produced by the hot-pressing technique. A range of HA-BG powder mixtures (30-50 wt% BG) was fully densified by hot pressing at temperatures as low as B7001-8001C. On the other hand, the HA-BG composites could not be densified by pressureless sintering because their composition was degraded due to a severe thermal reaction. The hot-pressed composites had significantly improved flexural strengths (B60 MPa) as compared with those subjected to pressureless sintering (B30 MPa) or the pure HA control (B40 MPa). The hot-pressed HA-BG composites showed significantly enhanced bioactivity in a simulated body fluid, as well as osteoblast cell activity with respect to the pure HA, confirming their excellent in vitro biocompatibility.
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I. Introduction
B IOCERAMICS, including hydroxyapatite (HA) and bioactive glasses (BGs), have been used for the regeneration of damaged and defective hard tissues. 1, 2 As a main inorganic component of bone, HA is known to form a direct contact with tissues without the formation of a fibrous intermediate layer. 2 However, the use of its synthetic form has often led to a limited regeneration rate of bone defects, which is attributable to its slow degradation rate and low bioactivity as compared with the biological form of apatite. 2, 3 Previous works have proven that synthetic HA in a dense form remains almost intact over several years in vivo. 4, 5 Some improvement in the bioactivity of HA has been obtained by modifying the apatite structure with other ions. 5, 6 BGs have also been extensively studied and are known to achieve direct apposition to bone through the newly formed apatite layer at the interface.
1,2 They are more dissolvable and have higher bone-forming ability than synthetic HA, which is due to their initial rapid surface reaction with the body fluid.
1,2,5 However, BGs are known to sometimes exhibit a more rapid dissolution rate than that required for the remodeling of human hard tissues. 5, 7 They are also known to possess extremely poor mechanical strength and toughness. The glass ceramics made from the BGs are thus often preferred for their mechanical benefits and lower dissolution rate, because of the crystalline phases present therein (mostly apatite and wollastonite). However, it is not easy to control exactly the type and amount of the phases formed in the glass ceramics. As such, when the crystalline phases with predetermined composition and amount are directly added to the BG composition, the composite is expected to possess good bioactivity and mechanical properties.
With this in mind, the authors aimed to produce HA-BG composites. Attempts to produce HA-BG composites have been made by several researchers; however, no successful work has yet been reported. In most cases, the HA and glass react vigorously to form unwanted crystalline phases, which normally have unidentified biological properties. [8] [9] [10] It has been almost impossible to densify HA-BG composites by the conventional sintering process without the undesirable occurrence of a thermal reaction and phase degradation.
The purpose of this study was to produce densified HA-BG composites retaining excellent bioactivity by means of the hot-pressing technique. Applying a pressure during sintering is believed to assist the densification of HA-BG by reducing the sintering temperature below the thermal reaction region. The effects of the hot pressing on the densification and thermal reaction in the HA-BG composites are examined, and the in vitro biological properties of the composites are addressed.
II. Experimental Procedures
HA powder (Alfa Aesar, Ward Hill, MA) was used after calcination at 12001C, followed by crushing and sieving down to 220 mm. The BG (designated ''53S'' by the Hench group 2 with a composition of 53.9% SiO 2 , 22.6% Na 2 O, 21.8% CaO, and 1.7% P 2 O 5 by mole) was fabricated from the precursors (SiO 2 , Na 2 HCO 3 , CaCO 3 , and P 2 O 5 ) and then used after crushing and pulverization. The HA and BG powders were wet mixed in ethanol at various ratios (30, 40, and 50 wt%). The mixture powders were dried, sieved, and packed in a carbon mold, and then densified by hot pressing at 30 MPa under nitrogen at various temperatures (6001-8001C) for 1 h. For the purpose of comparison, the HA-BG mixture powders were also pressurelessly sintered at various temperatures (6001-10001C) for 1 h.
The phase and morphology of the composites were characterized by X-ray diffraction (XRD; M18XHF-SRA, MAC Science Co., Yokohama, Japan) and scanning electron microscopy (SEM; JSM6360, JEOL, Tokyo, Japan), respectively. The density of the specimens was measured by the Archimedes method. The mechanical strength of the composites was observed using a four-point flexural configuration following the method described in our previous study. 11 The bioactivity of the composites was assessed by the formation of apatite on their surface in a simulated body fluid (SBF) following Kokubo's recipe. 12 The specimens (10 mm Â 10 mm Â 0.2 mm) were incubated in SBF at 371C for up to 14 days, and then their surface was evaluated with SEM. Moreover, the in vitro cellular responses to the HA-BG composites were assessed in terms of the cell proliferation by the MTT method and the detection of the expressed osteoblastic phenotype, alkaline phosphatase (ALP). The cell culturing and assaying protocols are fully described in our previous study. 5 Three specimens were tested for each condition, and the data were compared using ANOVA at a significance level of po0.05.
III. Results and Discussion
(1) HA-BG Dense Composite by Hot Pressing By the normal sintering process, it was almost impossible to obtain dense HA-BG composites with the compositions used in this study (30%-50% BG). However, hot pressing the composites significantly improved their sinterability. Figure 1 shows the typical SEM morphologies of the HA-30% BG composites obtained either by normal pressureless sintering (Fig. 1(A) ) or hot pressing ( Fig. 1(B) ) at 7501C. The pressureless-sintered composite was extremely porous, while the hot-pressed one was completely densified. This marked contrast in the morphology depending on the sintering technique was also observed for the other compositions (40% and 50% BG). The densities of the hot-pressed composites, as measured by the Archimedes method, were observed to almost reach the theoretical values when the hot-pressing temperatures of B7001-8001C were used (apparent porosity less than B5%). On the other hand, the pressureless-sintered specimens revealed apparent porosities as high as B35%-40% depending on the composition and sintering temperature. Even when the sintering temperature was increased, the enhancement in the densification was only minimal (porosities of B30% were still observed above 10001C). This poor sinterability has been described elsewhere as being one of the critical problems associated with HA-BG composites. [8] [9] [10] The poorly densified body could not be used effectively as replacements for hard tissues, due to its handling difficulties in surgical operations and mechanical breakdown under in vivo conditions. As an a priori index, the four-point flexural strength of the specimens was measured. The hot-pressed composites showed almost twice the strength (B60 MPa) of the pressureless-sintered specimens (B30 MPa). This improvement was due not only to the enhancement in the densification afforded by the hot pressing but also due to the composite effect of the two components (HA and BG). This is comprehensible when considering that the strength of pure HA in the dense form (used as a control) was B40 MPa, which was only slightly higher than that of the HA-BG porous composite, while being much lower than that of the HA-BG dense composite. Based on these results, it is considered that the production of the HA-BG dense composites using the hot-pressing technique improves the mechanical performance of HA.
Of special consideration in the HA-BG composites is the thermal reaction between the two components (HA and BG) and the consequent phase degradation. Figure 2 shows the phase evolution of the specimens as analyzed by XRD. When the HA-30% BG specimen was pressurelessly sintered at 7501C, a small amount of the b-tricalcium phosphate (b-TCP) phase was detected ( Fig. 2(A) ). However, it should be noted that the specimen obtained at this temperature was extremely porous. As the sintering temperature was increased to 10001C, the porosity was reduced slightly; however, many secondary phases (sodium calcium silicate, wollastonite, and b-TCP) were formed along with the consumption of the apatite phase (Fig. 2(B) ). Similar trends were observed in the other compositions, although there was a slight difference in the contents of the secondary phases.
On the other hand, hot pressing the HA-30% BG composition made it possible to obtain a dense composite with only a slight formation of a secondary phase (sodium calcium silicate) (Fig. 2(C) ). In practice, this newly formed phase has already been reported to be bioactive and developed as a bioactive crystalline phase in biomedical coatings.
13, 14 The bioactivity of the hot-pressed HA-BG will be discussed in the following section.
(2) In Vitro Biocompatibility of HA-BG The biological properties of the densified HA-BG composites were investigated in terms of their apatite-forming ability and osteoblastic cellular responses in vitro. For these evaluations, only the densified specimens could be used, as the cells could not attach and proliferate on the pressurelessly sintered porous specimens. For this reason, densified pure HA was used as a control and the HA-30% BG specimen was tested as a representative example of the developed composites. Figure 3 shows the change in the surface morphology of the samples after incubation in SBF for 14 days. On the surface of the pure HA specimen, some regions became white, while most appeared to be intact (Fig. 3(A) ). However, in the HA-BG composite, the whole surface was changed with the formation of granular deposits. A closer examination revealed that some apatitic crystals were deposited on the pure HA, but the degree of deposition was mild in most regions. On the other hand, the HA-BG composite showed more noticeable deposition of the crystallines. In practice, in the HA-BG composite, the precipitation of Ca-P was observed to be initiated within 3 days, while more than 10 days were required for the precipitation to begin on pure HA. Although, there are some limitations associated with this in vitro test, the data suggest that the HA-BG composite has better bioactivity than pure HA, as the apatite-forming ability in SBF is generally used as a bioactivity index and, thus, is often used to predict the bone-forming ability in vivo.
Along with this SBF test, the osteoblastic cellular responses to the HA-BG composite were examined. The viability of the cells as quantified by the MTT method was observed to be comparable on both substrates (pure HA and HA-BG composite) after 3 days of culturing, as shown in Fig. 4(A) . However, the cells on the composite were observed to possess a significantly higher level of osteoblastic activity (po0.05), as assessed by their ALP expression (Fig. 4(B) ). As ALP is a well-known phenotype of osteoblastic cells, it is generally regarded as an important measure of osteoblastic functional activity and subsequent bone forming ability. 6, 11 Based on the present findings, it is anticipated that the HA-BG composite may have a higher potential for the recruitment of osteoblastic cells and subsequent bone-forming process. Although the present in vitro studies are meaningful as a first step in the assessment of the biological potential of our newly developed material, these in vitro results could not be illustrated in direct extrapolation to the clinical performance. As such, more in-depth evaluations, particularly an in vivo animal study, are warranted in the near future.
IV. Summary and Conclusions
Biomedical composites constituted of HA and BG were produced by means of hot pressing. The HA-BG composites obtained by the conventional pressureless sintering were extremely porous and showed considerable thermal reaction and phase degradation. In contrast, the hot-pressed HA-BG composites were almost completely densified at B7001-8001C with minimal thermal reaction. The HA-BG composite produced in this study possessed better apatite-forming ability and osteoblastic activity in vitro than pure HA. The present observations suggest that the densified HA-BG composite may be potentially useful in the bone regeneration field.
